Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

New Jersey CVS Pharmacy Dispenses Breast Cancer Medicine Instead of Kids' Fluoride Tablets
A CVS pharmacy in Chatham, New Jersey has mistakenly distributed pills for the treatment of breast cancer to children instead of the fluoride pills that were prescribed. The pharmacy has acknowledged that it incorrectly dispensed the breast cancer fighting drug Tamoxifen instead of chewable Fluoride 0.5 mg tablets to children in possibly 50 families between December 2011 and February 2012. CVS Caremark has not explained how the mistake happened but they have said that no injuries due to the mix-up have been reported. The company has contacted and left messages for every family whose child was dispensed a 0.5 mg Fluoride prescription in the previous 60 days. Most families did not indicate that their children received incorrect pills. The company will continue to follow up with families who believe their children may have ingested incorrect medication. Fluoride helps prevent tooth decay and is usually prescribed by dentists for children. Tamoxifen is used to treat breast cancer in men and women and blocks the female hormone estrogen. For more information, please visit: http://newjerseyhills.com/chatham_courier/news/chatham-pharmacy-mistakenly-mixed-kids-fluoride-cancer-pills/article_76a6081e-63da-11e1-abff-0019bb2963f4.html and http://www.washingtonpost.com/business/industries/nj-cvs-pharmacy-distributes-breast-cancer-meds-to-children-instead-of-fluoride-pills/2012/03/02/gIQAx9PqnR_story.html
Learn More

FDA Warns about Drug Interaction - Taking Both Statins and HIV or Hepatitis C Drugs Increases Risk of Muscle Injury
The U.S. Food and Drug Administration (FDA) has issued updated recommendations for drug-drug interactions between drugs for human immunodeficiency virus (HIV) or hepatitis C virus (HCV) known as protease inhibitors and certain cholesterol-lowering drugs known as statins. Protease inhibitors and statins taken together may raise the blood levels of statins and increase the risk for muscle injury (myopathy). The most serious form of myopathy, called rhabdomyolysis, can damage the kidneys and lead to kidney failure and other serious complications. HIV and HCV protease inhibitors should never be taken (are contraindicated) with lovastatin (Altoprev, Mevacor) and simvastatin (Zocor). In other cases, the dose of statin may be need to be limited depending on the protease inhibitor and the statin. Examples of HIV protease inhibitors are: Atazanavir (Reyataz), Darunavir (Prezista), Fosamprenavir (Lexiva), Indinavr(Crixivan), Nelfinavir (Viracept), Saquinavir (Invirase), Tipranavir (Aptivus), and Lopinavir with Ritonavir (Kaletra). Examples of HCV protease inhibitors are: Boceprevir (Victrelis) and Telaprevir (Incivek). Examples of statins are: Lovastatin (Altoprev, Mevacor), Rosuvastatin (Crestor), Fluvastatin (Lescol), Atorvastatin (Lipitor), Pitavastatin (Livalo), Pravastatin (Pravachol), and simvastatin (Zocor) Products containing statins in combination with other drugs include: Advicor (lovastatin/niacin extended-release), Caduet (atorvastatin/amlodipine), Juvisync (simvastatin/sitagliptin), Simcor (simvastatin/niacin extended-release), and Vytorin (simvastatin/ezetimibe). To view a more detailed list of of these drug interactions and dosing limits, please visit: www.fda.gov/Drugs/DrugSafety/ucm293877.htm#dose For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/ucm293877.htm
Learn More

Date Published Title Drug Source
2012-03-05 New Jersey CVS Pharmacy Dispenses Breast Cancer Medicine Instead of Kids' Fluoride Tablets Sodium Fluoride MediGuard CRT
2012-03-02 FDA Warns about Drug Interaction - Taking Both Statins and HIV or Hepatitis C Drugs Increases Risk of Muscle Injury Indinavir FDA
2012-02-29 Prevnar Vaccine Recall Unlikely to Pose Health Risk Pneumococcal Conjugate Vaccine FDA
2012-02-29 GlaxoSmithKline Recalls All Lots of DynaCirc CR (Isradipine) Tablets Isradipine Manufacturer
2012-02-29 New Study Suggests Sleeping Pills May Raise Risk of Death Eszopiclone MediGuard CRT
2012-02-28 FDA Revises Dose Limitations for Lovastatin (Mevacor) and Lovastatin/Niacin (Advicor) Lovastatin FDA
2012-02-28 FDA Provides Safety Advice for Statins Atorvastatin FDA
2012-02-27 Glenmark Generics Recalls Birth Control Pills Due To Packaging Error that May Increase Risk of Unintended Pregnancies Ethinylestradiol with Norgestimate FDA
2012-02-26 FDA Issues Consumer Update about Grapefruit Juice and Medicine Interactions Cyclosporine FDA
2012-02-22 McNeil Consumer Healthcare Announces Recall of Infants’ TYLENOL Oral Suspension, 1 oz. Grape Due to Dosing System Complaints Manufacturer
2012-02-22 McNeil Consumer Healthcare Announces Recall of Infants’ TYLENOL Oral Suspension, 1 oz. Grape Due to Dosing System Complaints Acetaminophen Manufacturer
2012-02-19 McNeil Consumer Healthcare Announces Recall of Infants’ TYLENOL Oral Suspension, 1 oz. Grape Due to Dosing System Complaints Manufacturer
2012-02-17 Healthcare Professionals Advised That a Single Batch Of Clexane Syringe Needle Caps May Be Difficult To Remove Lovenox MHRA
2012-02-16 FDA Says Midodrine Will Continue to Be Available While Additional Studies Are Conducted Midodrine Hydrochloride FDA
2012-02-16 FDA and Manufacturers Warn about Conterfeit Avastin (Bevacizumab) Bevacizumab FDA
2012-02-13 FDA Issues Warning about Important Drug Interactions Between Victrelis (boceprevir) and Ritonavir-boosted Human Immunodeficiency Virus (HIV) Protease Inhibitors Lopinavir with Ritonavir FDA
2012-02-08 FDA Issues Safety Announcement: Proton Pump Inhibitors (PPIs) Possibly Associated with Clostridium Difficile-Associated Diarrhea (CDAD) Dexlansoprazole FDA
2012-02-02 Teva Pharmaceuticals USA, Inc Recalls Select Lots of Tetracycline Capsules 500 mg Tetracycline FDA
2012-02-02 Sanofi-aventis US, Inc. Recalls Several Lots of Lantus Insulin Glargine FDA
2012-02-02 Glenmark Generics Inc. Recalls Single Lot of Glenmark Clotrimazole Cream Clotrimazole FDA
Back to Consumer Med Safety